EMPASUS-L® Tablets
Empagliflozin 10 mg + Linagliptin 5 mg
Dual-Action Oral Antidiabetic Combination
Description
Product Specifications
| Specification | Details |
|---|---|
| Product Name | EMPASUS-L® |
| Product Type | Prescription Medicine |
| Therapeutic Category | Antidiabetic |
| Indication | Type 2 Diabetes Mellitus |
| Dosage Form | Tablet |
| Empagliflozin | 10 mg |
| Linagliptin | 5 mg |
| Strength | 10 mg/5 mg |
| Administration | Oral |
| Mechanism 1 | SGLT2 inhibition |
| Mechanism 2 | DPP-4 inhibition |
| Primary Purpose | Glycemic control |
| Weight-related effect | May support modest weight reduction through empagliflozin |
| Pack Size shown | 10 × 10 Tablets |
| Brand | EMPASUS-L® |
| Company | Sushruta Pharma |
| Prescription Status | Prescription medicine |
